SCHEMBL21313196

SCHEMBL21313196

CCCCc1c(-c2ccco2)nc(N)nc1-c1cc2ccccc2o1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 12/20 0.44
▸ GRM4 Q14833 1/20 0.41
▸ HPGD P15428 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ SIRT1 Q96EB6 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ADORA1 P30542 6/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ ADORA2B P29275 2/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12496138 0.92 GRM4 (0.45) GRM4HPGDKDM4ESIRT1SMN1; SMN2
SCHEMBL21313228 0.87 TLR8 (0.46) ADORA2AGRM4KDM4ENPSR1SMN1; SMN2
SCHEMBL21313152 0.87 ADORA2A (0.51) ADORA2AHPGDKDM4ENPSR1SMN1; SMN2
SCHEMBL21313180 0.84 ADORA2A (0.45) ADORA2AGRM4HPGDKDM4ESMN1; SMN2
SCHEMBL21313154 0.84 ADORA2A (0.46) ADORA2AGRM4HPGDKDM4ESMN1; SMN2
SCHEMBL12495884 0.84 HDAC3 (0.41) GRM4HPGDKDM4ESIRT1SMN1; SMN2
SCHEMBL21313237 0.83 ADORA2A (0.42) ADORA2AGRM4HPGDKDM4ESMN1; SMN2
SCHEMBL12495836 0.83 ADORA2A (0.55) ADORA2AHPGDKDM4ENPSR1SMN1; SMN2
SCHEMBL21313249 0.82 GRM4 (0.45) ADORA2AGRM4KDM4ESMN1; SMN2ADORA1
SCHEMBL21313195 0.82 DHFR (0.38) GRM4HPGDKDM4ESMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3195867-B1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR V V I (CZ) 2019-09-04 — — EP claimed
Send feedback